Current Search Criteria: Intervention: Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®
Found 43 matching trials
Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents PHASE2 This study was designed to evaluate the antibody response to a Menactra® bo...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunology and Safety of Menactra® in Children in Saudi Arabia PHASE3 This study will be conducted among children in Saudi Arabia who previously ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children PHASE2 The study investigated safety profile and the antibody responses to an expe...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years PHASE3 The purpose of the study was to evaluate the immunogenicity and describe th...
Show More Location
Investigational Site
Learn More & Join Trial
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine PHASE2 The purpose of this trial is to describe the safety and antibody response t...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects PHASE4 The aim of this study was to collect further information regarding an incre...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US PHASE3 The purpose of this study was to compare the immunogenicity and describe th...
Show More Location
Birmingham Pediatric Associates Site Number : 8400026
Learn More & Join Trial
Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation PHASE3 The purpose of this study is to assess the immunogenicity and safety of Men...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico PHASE3 Primary Objective:
1. To describe the vaccine seroprotection (antibody tit...
Show More Location
Investigational Site Number :4840001
Treatments Being Tested
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Measles, Mumps, and Rubella Virus Vaccine Live Pneumococcal 13-valent Conjugate Vaccine Diphtheria, Tetanus, Pertussis (Acellular, Component) Poliomyelitis (inactivated) Vaccine, and Haemophilus influenza type b Conjugate Vaccine Hepatitis B Vaccine Rotavirus Vaccine, Live, Pentavalent Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b conjugate vaccine Learn More & Join Trial
Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® PHASE2 The purpose of this study is to evaluate the immunogenicity and safety of t...
Show More Location
Multiple Locations
Learn More & Join Trial